HHS Study On Drug Price Increases, Costs, Access Required In Funding Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Omnibus funding bill requires a government study on drug price increases and costs (net of rebates) and patient access and outcomes in Medicare Parts B and D, Medicaid and the Department of Veterans Affairs.